We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Puretech Health Plc | LSE:PRTC | London | Ordinary Share | GB00BY2Z0H74 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.0% | 152.00 | 0.00 | 00:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 150.60 | 151.20 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Home Health Care Services | USD 23.75M | USD -50.35M | USD -0.1839 | -8.27 | 416.28M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 17:40:49 | O | 17,990 | 151.163 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 04/12/2023 | 07:00 | UKREG | PureTech Health PLC Transaction in Own Shares |
| 01/12/2023 | 14:29 | ALNC |  TRADING UPDATES: N4 launches investor hub; Capricorn production falls |
| 01/12/2023 | 07:00 | UKREG | PureTech Health PLC Transaction in Own Shares |
| 30/11/2023 | 07:00 | UKREG | PureTech Health PLC Transaction in Own Shares |
| 29/11/2023 | 15:07 | RNSNON | PureTech Health PLC PRTC: Karuna's NDA for KarXT Accepted by U.S. FDA |
| 29/11/2023 | 07:00 | UKREG | PureTech Health PLC Transaction in Own Shares |
| 28/11/2023 | 07:00 | UKREG | PureTech Health PLC Transaction in Own Shares |
| 27/11/2023 | 07:00 | UKREG | PureTech Health PLC Transaction in Own Shares |
| 24/11/2023 | 07:00 | UKREG | PureTech Health PLC Transaction in Own Shares |
| 23/11/2023 | 07:00 | UKREG | PureTech Health PLC Transaction in Own Shares |
Puretech Health (PRTC) Share Charts1 Year Puretech Health Chart |
|
1 Month Puretech Health Chart |
Intraday Puretech Health Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 30/11/2023 | 10:59 | PureTech Health - innovative healthcare | 1,580 |
| 22/7/2018 | 20:35 | PureTech Health (PRTC) One to Watch Monday | - |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 07:15:14 | 151.16 | 17,990 | 27,194.22 | O |
| Top Posts |
|---|
Posted at 03/12/2023 08:20 by Puretech Health Daily Update Puretech Health Plc is listed in the Home Health Care Services sector of the London Stock Exchange with ticker PRTC. The last closing price for Puretech Health was 152p.Puretech Health currently has 273,866,153 shares in issue. The market capitalisation of Puretech Health is £412,442,426. Puretech Health has a price to earnings ratio (PE ratio) of -8.19. This morning PRTC shares opened at - |
Posted at 29/11/2023 16:11 by edwardt karuna approved - this derisks prtc a lot imho. |
Posted at 23/5/2023 13:02 by af004 Are the share buy backs achieving anything? |
Posted at 26/3/2023 21:41 by rambutan2 The other listed stakes - all currently rather struggling and worth little ($35m ish), albeit with plenty of potential upside:Akili 14.5% stake: Vor 4.1% stake: Gelesis 23.3% stake: See pgs 46-49 for brief details: |
Posted at 12/12/2022 16:05 by rogers49 Agree, PRTC should be a lot higher. |
Posted at 09/12/2022 23:02 by rambutan2 Agree, I've always had high hopes for their tech. |
Posted at 11/10/2022 07:15 by liam1om So PRTC sees a large drop on offer talks. You would assume once offer talks were off the price rebounds? |
Posted at 07/10/2022 11:38 by sspurt It looks like a reverse takeover to me - I can't see any logic in PRTC selling out as they have a cash runway to at least 2026 and cash/liquid assets worth more than the current mkt cap so everything else is in for free. Nektar need rescuing probably I am guessing but our management team have some serious explaining to do if they are going to get our shareholders to agree to this proposal. Not seen any broker research, both PH and Lib silent as yet. |
Posted at 07/10/2022 07:38 by 74tom It's not mad at all, the market is pricing in a likely all-share deal because Nektar don't have the capital to buy PRTC outright...Cash of ~$630m at 30/06 and they had burned through $160m in the prior 6 month period... PRTC has a market cap of $685m at 218p.. it's not difficult to do the maths and realise the offer will be in Nektar shares. Do big PRTC holders want to own Nektar shares? The answer appears to be no... |
Posted at 22/8/2022 08:07 by 74tom “Following the closing of the business combination, PureTech holds 12,549,207 shares of Akili common stock“Anyone spot that Akili went crazy after hours Friday hitting $40?! That would value PRTC’s holding at £425m / £1.50 a share… I presume PRTC will reduce their holding if big volume hits Akili today… |
Posted at 19/5/2022 20:46 by deadly nightshade It's strange the low buy back volumes every day, is that a sign that there is very few floating shares to buy? In which case it makes you wonder why the share price basically halved for a reason that I still can't fathom out. Really can't get my head around the markets these days it's really weird this can still be valued at a share price it was sitting at 3 year ago when we had nothing like the progress or cash on the balance sheet we have now. Why this is not on the radar of a large pharma for a takeout is beyond me this would be pocket money to some of the big companies to buy up |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
